Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.5 HKD | +0.64% | -6.75% | +12.44% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.44% | 959M | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+59.95% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+5.02% | 8.79B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines' Loss Widens in 2023